The Nanotechnology Knowledge Transfer Network (NanoKTN) has confirmed the details of its workshop at this year's Bio event in Chicago, US.
The workshop, to be co-hosted by Dr Mike Fisher, healthcare and life sciences theme manager at the NanoKTN, and Tony Bradshaw, co-director at the Healthtech and Medicines KTN, will explore the technical and commercial issues surrounding regenerative medicine.
According to the NanoKTN, new products in regenerative medicine are required to help solve the issues of an ageing population.
Many countries are investing in stem cell research and regenerative medicine, but the final step of commercialisation is still a problem.
The company believes that tissue engineering and regenerative medicine will solve some of the medical needs faced by healthcare professions today, especially in terms of the issues of the ageing population.
Two research areas of particular importance are the development of conditions for reliable cell growth and the development of nano-structured materials that are biocompatible and that integrate with both the host and donor cells.
The workshop will cover the challenges faced in integrating the two disciplines of biology and material science to produce tissue-engineered products.
The panel will also address the business models that companies will need to adopt in order to successfully commercialise these products.
Delegates will also learn about complex regenerative medicine from a product development perspective.
The Bio International Convention, which is targeted at the biotechnology industry, will feature keynotes and sessions from policymakers, scientists, chief executive officers and celebrities.
This year's plenary sessions will include a debate between George W Bush and Bill Clinton and a plenary by Regina Benjamin, US surgeon general.
